To some extent I agree. The only near-term positive news in my view are these apparent non-binding asset sales. Insto analysts are now reporting to their clients (e.g. Macquarie) on concerns revolving around a highly dilutive capital raising event if these sales do not occur in time.
There's no specific details on these agreements in the recent HY (first news article appeared in Nov 2022 on Zest acq, source: Trust Me Bro). Surely it'd be worthy to update shareholders on some minor details, which assets exactly are they in negs with, initial ballpark amounts, interested parties, timeframes, etc.
Similarly to takeover disclosures, initial offers and details are released to ASX as price sensitive news as it may affect the valuation or in this case from now Deloitte audited report the continuation of the company.
Not financial advice, only my opinion is stated here.
Ann: H1 FY23 Results Update, page-116
Add ZIP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.36 |
Change
0.050(1.51%) |
Mkt cap ! $4.386B | |||
| Open | High | Low | Value | Volume |
| $3.31 | $3.40 | $3.26 | $37.72M | 11.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 800 | $3.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.36 | 284106 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ZIP (ASX) Chart |